Medium to long-term follow-up of the SelectSecure 3830 pacing lead in pediatric patients reveals potential difficulties with lead advancement due to scar tissue and risk of lead malfunction.
May warrant monitoring of aging pediatric leads; hypothesis-generating for scar-related risks and extraction strategies.
Select Secure 3830 pacemaker leads have been shown to be safer and more advantageous in the short term for pediatric pacemaker patients compared to previous pacemaker lead designs. The two case studies outlined below illustrate potential pitfalls in the medium to long term care of patients with this pacing lead. Further research on the long term risks/benefits of these leads must be performed to determine the long term functionality of the Select Secure 3830 lead.
No takes yet. Share an insight, caveat, or question.
Michael W. Rudokas (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: